Signaling pathways
-
BA2780 CR-1-31-BSummary: CR-1-31-B is a synthetic Rocaglate and a potent inhibitor. - BA2781 MinnelideSummary: Minnelide is a derivative of tretinoin lactone that has shown antitumor activity in many tumor types (especially in pancreatic cancer).
- BA2782 JX06Summary: JX06 is a potent, selective, covalent inhibitor.
- BA2783 BTdCPUSummary: BTdCPU is a heme-regulated inhibitory kinase activator that promotes phosphorylation and induces apoptosis in (Dex)-resistant cancer cells.
- BA2784 FL118Summary: FL118 (10,11-(Methylenedioxy)-20(S)-camptothecin), a camptothecin (;HY-16560) analog, is an orally effective inhibitor.
- BA2785 BMS-536924Summary: BMS-536924 is an orally active, competitive and selective inhibitor of insulin-like growth factor receptor kinase and insulin receptor at 100nM and 73nM, respectively.
- BA2786 GSK-843Summary: GSK-843 (GSK'843) is a receptor-interacting protein kinase 3 inhibitor.
- BA2787 AOH1160Summary: AOH1160 is a potent orally available small molecule inhibitor of proliferating cell nuclear antigen.
- BA2788 LysophosphatidylcholinesSummary: Lysophosphatidylcholines are orally active lysophosphatidylcholines and a component of oxidized low-density lipoprotein (LDL).
- BA2789 PD0166285Summary: PD0166285 is a substrate for P-gp.